← Open Payments lookup

ANGIE HICKS-MASTER: Open Payments

NPI 1255405353 · MANILA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$676 in 37 payments from 9 companies in 2025. Trend: 2023 $440 · 2024 $476 · 2025 $676

Food & beverage: $676
CompanyPaymentsAmount
ABBVIE INC.16$267
Otsuka America Pharmaceutical, Inc.7$116
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$72
Neurocrine BioSciences, Inc.4$67
Alkermes, Inc.2$50
Takeda Pharmaceuticals U.S.A., Inc.2$42
Janssen Pharmaceuticals, Inc1$26
Vanda Pharmaceuticals Inc.1$21
Axsome Therapeutics, Inc.1$15

Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, ARISTADA, TRINTELLIX, INVEGA SUSTENNA, FANAPT.

Industry payments across AR — which companies pay providers there.